Access to anti-retroviral drugs, male in Togo
Togo: Access to anti-retroviral drugs, male was 86.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Togo, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Togo recorded 86.0% for access to anti-retroviral drugs, male in 2024. That is the highest value across all 25 years on record.
That represents a change of up 10.3% on the previous year and up 186.7% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Togo peaked at 86.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Togo 30th out of 141 countries with data for 2024, putting it in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Togo, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 1.0% | — |
| 2004 | 3.0% | +200.0% |
| 2005 | 7.0% | +133.3% |
| 2006 | 8.0% | +14.3% |
| 2007 | 9.0% | +12.5% |
| 2008 | 13.0% | +44.4% |
| 2009 | 20.0% | +53.8% |
| 2010 | 30.0% | +50.0% |
| 2011 | 34.0% | +13.3% |
| 2012 | 24.0% | -29.4% |
| 2013 | 27.0% | +12.5% |
| 2014 | 30.0% | +11.1% |
| 2015 | 36.0% | +20.0% |
| 2016 | 39.0% | +8.3% |
| 2017 | 42.0% | +7.7% |
| 2018 | 53.0% | +26.2% |
| 2019 | 61.0% | +15.1% |
| 2020 | 66.0% | +8.2% |
| 2021 | 67.0% | +1.5% |
| 2022 | 74.0% | +10.4% |
| 2023 | 78.0% | +5.4% |
| 2024 | 86.0% | +10.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 6.1% | 0.0% | 20.0% | 10 |
| 2010s | 37.6% | 24.0% | 61.0% | 10 |
| 2020s | 74.2% | 66.0% | 86.0% | 5 |
Countries ranked near Togo
More gender data for Togo
- Child population (UN estimates and projections) 4,049 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 1.27 % change on previous year (2030)
- Population 6,744 (2030)
- Working-age population (UN estimates and projections) 6,744 (2030)
- Population (UN estimates and projections), annual growth rate 2.58 % change on previous year (2030)
- Age population, age 00, female, interpolated 129,302 (2025)
- Age population, age 00, male, interpolated 131,980 (2025)
- Age population, age 01, female, interpolated 127,260 (2025)
- Age population, age 01, male, interpolated 129,478 (2025)
- Age population, age 02, female, interpolated 117,518 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Togo?
- Access to anti-retroviral drugs, male in Togo was 86.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Togo?
- The highest recorded value was 86.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Togo?
- The lowest recorded value was 0.0% in 2000.
- How does Togo rank for access to anti-retroviral drugs, male?
- Togo ranks 30th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Togo?
- Over the last ten years it is up 186.7%. The long-run trend across the full record is volatile.
- Where does this Togo data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.